Successful use of gonadotropin-releasing hormone agonist in a patient with pulmonary endometriosis.
A 26-year-old single female was admitted to hospital with recurrent chest pain, cough and hemoptysis. The symptoms developed 5 months before admission coinciding with menstruation. The disease was diagnosed as pulmonary endometriosis. She was treated with a long-acting gonadotropin-releasing hormone analogue (GnRH agonist; sustained-release leuprolide acetate, 3.75 mg/month, i.m.) for 6 months. She remained asymptomatic for 16 months with regular menstruation even after discontinuing the treatment. This indicates that the initial treatment of pulmonary endometriosis with a GnRH agonist is an acceptable medical alternative, especially in patients with a short duration of the disease from the onset of the chest symptoms.
Koizumi
T
T
Department of Medicine, Komoro Kosei Sogo Hospital, Matsumoto, Japan.
Inagaki
H
H
Takabayashi
Y
Y
Kubo
K
K
D000328:Adult; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004715:Endometriosis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage*; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D003692:Delayed-Action Preparations; D016729:Leuprolide